ssgj-707
mAbexperimentalBi-specific
Clinical trial activity
11 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
10
Phase 3
4
Phase 4
0
Earliest trial started May 15, 2024 (NCT06361927)
Timeline
Indications
Studied for
- Carcinoma, Hepatocellular · Phase 1/Phase 2
- Carcinoma, Non-Small-Cell Lung · Phase 3
- Carcinoma, Renal Cell · Phase 1/Phase 2
- Colonic Diseases · Phase 3
- Colorectal Neoplasms · Phase 3
- Digestive System Diseases · Phase 3
- Digestive System Neoplasms · Phase 3
- Endometrial Neoplasms · Phase 2
- Gastrointestinal Diseases · Phase 3
- Gastrointestinal Neoplasms · Phase 3
- Intestinal Diseases · Phase 3
- Intestinal Neoplasms · Phase 3
- Kidney Neoplasms · Phase 1/Phase 2
- Liver Neoplasms · Phase 1/Phase 2
- Lung Neoplasms · Phase 3
- Neoplasms by Site · Phase 3
- Rectal Diseases · Phase 3
- Small Cell Lung Carcinoma · Phase 3
Mechanism of action
- Programmed cell death 1 ligand 1INHIBITOR
CD274 inhibitor
EGFR inhibitor
Chemistry & pharmacology
- Multi-specific
- Yes (Bi-specific)
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07222800 | Phase 3 | Dec 12, 2025 | Pfizer |
| NCT07222566 | Phase 3 | Dec 5, 2025 | Pfizer |
| NCT07227415 | Phase 1/Phase 2 (Phase 2) | Dec 4, 2025 | Pfizer |
| NCT07227012 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2025 | Pfizer |
| NCT07227298 | Phase 1/Phase 2 (Phase 2) | Nov 17, 2025 | Pfizer |
| NCT07226999 | Phase 2/Phase 3 (Phase 3) | Nov 17, 2025 | Pfizer |
| NCT06980272 | Phase 3 | Jun 20, 2025 | Sunshine Lake Pharma Co., Ltd. |
| NCT06522828 | Phase 2 | Oct 10, 2024 | Sunshine Lake Pharma Co., Ltd. |
| NCT06493760 | Phase 2 | Sep 3, 2024 | Sunshine Lake Pharma Co., Ltd. |
| NCT06412471 | Phase 2 | Jul 26, 2024 | Sunshine Lake Pharma Co., Ltd. |
| NCT06361927 | Phase 2 | May 15, 2024 | Sunshine Lake Pharma Co., Ltd. |
Showing 11 of 11 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pfizer | For profit | 6 | 6 | 2 | 2025 |
| Sunshine Lake Pharma Co., Ltd. | For profit | 5 | 5 | 2 | 2024 |
2 organizations
Page 1 / 1